266 related articles for article (PubMed ID: 27637455)
1. The effects of dietary and herbal phytochemicals on drug transporters.
Li Y; Revalde J; Paxton JW
Adv Drug Deliv Rev; 2017 Jul; 116():45-62. PubMed ID: 27637455
[TBL] [Abstract][Full Text] [Related]
2. The role of ABC and SLC transporters in the pharmacokinetics of dietary and herbal phytochemicals and their interactions with xenobiotics.
Li Y; Lu J; Paxton JW
Curr Drug Metab; 2012 Jun; 13(5):624-39. PubMed ID: 22475331
[TBL] [Abstract][Full Text] [Related]
3. The effects of flavonoids on the ABC transporters: consequences for the pharmacokinetics of substrate drugs.
Li Y; Paxton JW
Expert Opin Drug Metab Toxicol; 2013 Mar; 9(3):267-85. PubMed ID: 23289831
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota in phytopharmacology: A comprehensive overview of concepts, reciprocal interactions, biotransformations and mode of actions.
Dey P
Pharmacol Res; 2019 Sep; 147():104367. PubMed ID: 31344423
[TBL] [Abstract][Full Text] [Related]
5. Targeted pharmacotherapies for defective ABC transporters.
Vauthier V; Housset C; Falguières T
Biochem Pharmacol; 2017 Jul; 136():1-11. PubMed ID: 28245962
[TBL] [Abstract][Full Text] [Related]
6. Heterocyclic cyclohexanone monocarbonyl analogs of curcumin can inhibit the activity of ATP-binding cassette transporters in cancer multidrug resistance.
Revalde JL; Li Y; Hawkins BC; Rosengren RJ; Paxton JW
Biochem Pharmacol; 2015 Feb; 93(3):305-17. PubMed ID: 25543853
[TBL] [Abstract][Full Text] [Related]
7. Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxia.
To KK; Poon DC; Wei Y; Wang F; Lin G; Fu LW
Biochem Pharmacol; 2015 Sep; 97(1):27-37. PubMed ID: 26206183
[TBL] [Abstract][Full Text] [Related]
8. The antiepileptic drug lamotrigine is a substrate of mouse and human breast cancer resistance protein (ABCG2).
Römermann K; Helmer R; Löscher W
Neuropharmacology; 2015 Jun; 93():7-14. PubMed ID: 25645391
[TBL] [Abstract][Full Text] [Related]
9. The application of P-gp inhibiting phospholipids as novel oral bioavailability enhancers - An in vitro and in vivo comparison.
Weinheimer M; Fricker G; Burhenne J; Mylius P; Schubert R
Eur J Pharm Sci; 2017 Oct; 108():13-22. PubMed ID: 27590127
[TBL] [Abstract][Full Text] [Related]
10. Convallatoxin: a new P-glycoprotein substrate.
Gozalpour E; Greupink R; Bilos A; Verweij V; van den Heuvel JJ; Masereeuw R; Russel FG; Koenderink JB
Eur J Pharmacol; 2014 Dec; 744():18-27. PubMed ID: 25264938
[TBL] [Abstract][Full Text] [Related]
11. Utilizing Ayurvedic literature for the identification of novel phytochemical inhibitors of botulinum neurotoxin A.
Yalamanchili C; Manda VK; Chittiboyina AG; Guernieri RL; Harrell WA; Webb RP; Smith LA; Khan IA
J Ethnopharmacol; 2017 Feb; 197():211-217. PubMed ID: 27469199
[TBL] [Abstract][Full Text] [Related]
12. An overview of ABC and SLC drug transporter gene regulation.
Chen QX; Hu HH; Zhou Q; Yu AM; Zeng S
Curr Drug Metab; 2013 Feb; 14(2):253-64. PubMed ID: 23116109
[TBL] [Abstract][Full Text] [Related]
13. Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?
Chen F; Wen Q; Jiang J; Li HL; Tan YF; Li YH; Zeng NK
J Ethnopharmacol; 2016 Feb; 179():253-64. PubMed ID: 26723469
[TBL] [Abstract][Full Text] [Related]
14. High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4).
Cheung L; Flemming CL; Watt F; Masada N; Yu DM; Huynh T; Conseil G; Tivnan A; Polinsky A; Gudkov AV; Munoz MA; Vishvanath A; Cooper DM; Henderson MJ; Cole SP; Fletcher JI; Haber M; Norris MD
Biochem Pharmacol; 2014 Sep; 91(1):97-108. PubMed ID: 24973542
[TBL] [Abstract][Full Text] [Related]
15. Purple corn silk: A potential anti-obesity agent with inhibition on adipogenesis and induction on lipolysis and apoptosis in adipocytes.
Chaiittianan R; Sutthanut K; Rattanathongkom A
J Ethnopharmacol; 2017 Apr; 201():9-16. PubMed ID: 28257978
[TBL] [Abstract][Full Text] [Related]
16. Novel drug transporter substrates identification: An innovative approach based on metabolomic profiling, in silico ligand screening and biological validation.
Nies AT; König J; Leuthold P; Damme K; Winter S; Haag M; Masuda S; Kruck S; Daniel H; Spanier B; Fromm MF; Bedke J; Inui KI; Schwab M; Schaeffeler E
Pharmacol Res; 2023 Oct; 196():106941. PubMed ID: 37775020
[TBL] [Abstract][Full Text] [Related]
17. Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters.
Sasabe H; Shimokawa Y; Shibata M; Hashizume K; Hamasako Y; Ohzone Y; Kashiyama E; Umehara K
Antimicrob Agents Chemother; 2016 Jun; 60(6):3497-508. PubMed ID: 27021329
[TBL] [Abstract][Full Text] [Related]
18. Regulatory roles of phytochemicals on circular RNAs in cancer and other chronic diseases.
Zhang S; Long F; Lin H; Wang X; Jiang G; Wang T
Pharmacol Res; 2021 Dec; 174():105936. PubMed ID: 34653635
[TBL] [Abstract][Full Text] [Related]
19. Drug transporters in drug efficacy and toxicity.
DeGorter MK; Xia CQ; Yang JJ; Kim RB
Annu Rev Pharmacol Toxicol; 2012; 52():249-73. PubMed ID: 21942630
[TBL] [Abstract][Full Text] [Related]
20. Phytochemical and Over-The-Counter Drug Interactions: Involvement of Phase I and II Drug-Metabolizing Enzymes and Phase III Transporters.
Truong VL; Jun M; Jeong WS
J Med Food; 2021 Aug; 24(8):786-805. PubMed ID: 34382862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
